Notably, while BRCA1 promoter variants influencing breast and ovarian cancer risk have been reported earlier [141, 142], the finding by Evans et al. is the first to link such variants to BRCA1 methylation status. The gene discussed is BRCA1; the disease is ovarian cancer.